e-learning
resources
Virtual 2020
Tuesday, 08.09.2020
Part II: From symptoms to diagnosis in primary care
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The blood (vessels) and the lung: what the general practitioner needs to know about circulation (a bit of heart) and the lungs
A. Vonk Noordegraaf (Amsterdam, Netherlands)
Source:
Virtual Congress 2020 – Part II: From symptoms to diagnosis in primary care
Session:
Part II: From symptoms to diagnosis in primary care
Session type:
Primary care session
Number:
4454
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Vonk Noordegraaf (Amsterdam, Netherlands). The blood (vessels) and the lung: what the general practitioner needs to know about circulation (a bit of heart) and the lungs. Virtual Congress 2020 – Part II: From symptoms to diagnosis in primary care
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: Diagnostic tools for Obstructive Sleep Apnoea in adults and children
Expert interview: Physiological classification of lung function impairment
Occupational exposures to respiratory diseases: A case-based discussion
Related content which might interest you:
Ireland needs healthier airways and lungs: the evidence (INHALE)
Source: Eur Respir J 2004; 24: 189
Year: 2004
Is pulmonary rehabilitation (PRP) effective in restrictive lung disease (RLD)?
Source: Eur Respir J 2004; 24: Suppl. 48, 667s
Year: 2004
CF lung disease starts in the peripheral airways. Does it?
Source: Annual Congress 2008 - Cystic fibrosis: new mechanisms, monitoring and treatment tools
Year: 2008
Effects of a 3 week rehabilitation program on COPD patient’s endothelial function, blood vessel elasticity.
Source: International Congress 2017 – Latest insights into pulmonary rehabilitation in COPD
Year: 2017
Is the primary care (PC) office the right setting for spirometry to detect COPD?
Source: Annual Congress 2010 - From diagnosis to disease management in primary care
Year: 2010
Do site or therapist affect drop out rate in pulmonary rehabilitation (PR)?
Source: Annual Congress 2009 - Respiratory physiotherapy assessment
Year: 2009
Why should we care for the vessels in interstitial lung disease?
Source: Virtual Congress 2020 – European Reference Network for rare lung diseases (ERN-LUNG): acting for improved cross-border management of rare diseases
Year: 2020
Interstitial lung diseases: is there a place for a rehabilitation program?
Source: Annual Congress 2005 - PG15 - Therapeutic options for interstitial lung diseases in 2005
Year: 2005
Is it the heart or lung that fails?
Source: International Congress 2019 – Clinical Grand Round
Year: 2019
How do mechanical insufflation:exsufflation (MI:E) settings influence flow rates and sputum movement? A bench study using a paediatric lung model
Source: International Congress 2014 – Assessment and techniques of physiotherapy: from healthy subjects to critical patients
Year: 2014
Assessing risk in pulmonary arterial hypertension: what we know, what we don't
Source: Eur Respir J, 50 (2) 1701353; 10.1183/13993003.01353-2017
Year: 2017
Do we need local controls for multi-centre trials? Lung function measurements in 3 UK centres
Source: Annual Congress 2005 - New lung function techniques in paediatric pulmonology
Year: 2005
End points in pulmonary arterial hypertension: the way forward
Source: Eur Respir J 2004; 23: 947-953
Year: 2004
Morphological and molecular alterations of pulmonary vasculature in a pig model with increased pulmonary blood flow and pressure compared to "pulmonary plexogenic arteriopathy" (PPA) in children
Source: Annual Congress 2007 - Pulmonary hypertension
Year: 2007
Application and interpretation in RCT's
Source: Research Seminar 2006 - Preventing respiratory sequelae in children diagnosed with cystic fibrosis by newborn screening
Year: 2006
Red blood cell distribution width in patients with chronic obstructive lung disease:how is changed in exacerbation?
Source: International Congress 2017 – Airway disease and exacerbations
Year: 2017
The patient tells it! The importance of patient's quality of life perception in pulmonary arterial hypertension risk assessment
Source: Eur Respir J, 57 (2) 2004376; 10.1183/13993003.04376-2020
Year: 2021
The removal of the tracheostomy in patients showing stable clinical and arterial blood gases: experience in our semi-intensive respiratory unit (SRU)
Source: Eur Respir J 2001; 18: Suppl. 33, 389s
Year: 2001
Does pulmonary rehabilitation (PR) affect dysfunctional breathing (DB) in asthmatics?
Source: Virtual Congress 2020 – Aspects of pulmonary rehabilitation: part 1
Year: 2020
Measuring the effect of education in pulmonary rehabilitation (PR) using the lung information needs questionnaire (LINQ)
Source: Annual Congress 2007 - Pulmonary rehabilitation beyond training
Year: 2007
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept